. A
recent review by the U.S. Preventive Services Task Force
gave ABI screening an indeterminate rating, stating that
there was insufﬁcient evidence to assess the balance of
beneﬁts and harms.39 The SVS-commissioned meta-analysis1 demonstrates that ABI testing may incrementally
improve cardiovascular risk prediction, but existing

evidence does not support broad population screening
of asymptomatic patients for PAD. However, future
studies may identify